EPAM Forensic analysis

Trading Setup & Entry Strategy

EPAM is currently in a severe technical downtrend, trading significantly below both the 50-day SMA ($122.84) and the 200-day SMA ($161.94). With an RSI of 36.13, the stock is approaching oversold territory but momentum remains negative.

• >Entry Strategy: Do NOT chase the 5% move this week. We are looking for a base. Enter 30% of target position at $95.00 (a re-test of recent lows/psychological support). Add 40% on a confirmed breakout above the 10-day SMA ($97.70). Reserve 30% for a post-earnings trend reversal confirmation.
• >Stop Loss: $84.50 (Hard Stop). This is just below the lower Bollinger Band ($85.58) and recent swing low. A breach here invalidates the bottoming thesis.
• >Take Profit: Target $120.00 (initial resistance at the 50-day SMA) and $135.00 (gap fill).
• >Risk/Reward: Targeting a 1:2.5 ratio.

Executive Summary

EPAM is navigating a transition phase, dealing with heavy SBC (Stock-Based Compensation) and cost optimization restructuring in a high-interest rate environment. While Q1 revenue grew 7.6% YoY, profitability remains under pressure from geopolitical headwinds and operational restructuring. The stock is a classic 'value trap' candidate that requires strict technical discipline to trade.

Financial Health & Forensic Flags

• >Revenue Quality: Revenue growth (7.6% YoY) is slowing, and reliance on 'Time-and-materials' contracts (approx. 78% of revenue) exposes the firm to macro-spending pullbacks.
• >SBC Issues: High SBC expenses ($49.9M in Q1 2026) act as a continuous dilution drag on shareholders.
• [CRIT]Forensic Flag: Significant cash outflow in Q1 2026 ($36.36M used in operating activities vs. inflow in 2025) due to high variable compensation and tax payments.

Technical Analysis & Trade Timing

• >Trend: BEARISH_DOWNTREND. Price is roughly 38% below the 200-day SMA, confirming a long-term liquidation trend.
• >Momentum: MACD is showing a faint BULLISH divergence, suggesting the rate of decline is slowing. However, without a clean break above the 10-day SMA, the 'knife' is still falling.

Short-Term Trading Strategy (2-5 Days)

• >Timeframe: Swing Trade (2–5 Days).
• >Position Sizing: 3% of portfolio.
• >Strategy: Wait for a test of $95.00. If the stock holds this level on elevated volume, initiate the 30% tranche.
• >Catalyst: Focus on any commentary regarding future demand in their 'Financial Services' vertical, which showed 12.2% growth in Europe, providing a potential bright spot.

One-Liner Thesis: EPAM is a high-quality franchise currently suffering from 're-rating' trauma; wait for a confirmed technical base at $95 before initiating a long position in this structurally challenged but oversold asset.